KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) Profit After Tax (2016 - 2026)

Gilead Sciences filings provide 17 years of Profit After Tax readings, the most recent being $2.2 billion for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 22.43% to $2.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 billion, a 1672.92% increase, with the full-year FY2025 number at $8.5 billion, up 1672.92% from a year prior.
  • Profit After Tax hit $2.2 billion in Q4 2025 for Gilead Sciences, down from $3.1 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $3.1 billion in Q3 2025 to a low of -$4.2 billion in Q1 2024.
  • Median Profit After Tax over the past 5 years was $1.6 billion (2021), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Profit After Tax: soared 8316.67% in 2023 and later plummeted 512.87% in 2024.
  • Gilead Sciences' Profit After Tax stood at $400.0 million in 2021, then surged by 303.5% to $1.6 billion in 2022, then fell by 11.46% to $1.4 billion in 2023, then increased by 24.77% to $1.8 billion in 2024, then grew by 22.43% to $2.2 billion in 2025.
  • The last three reported values for Profit After Tax were $2.2 billion (Q4 2025), $3.1 billion (Q3 2025), and $2.0 billion (Q2 2025) per Business Quant data.